Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C UCB J PET Study
可卡因使用障碍中异常的突触可塑性:11C UCB J PET 研究
基本信息
- 批准号:10211330
- 负责人:
- 金额:$ 75.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AbstinenceAdmission activityAffectAgeAlcohol consumptionAnimalsAnteriorBasic ScienceBehaviorBindingBrainChronicClinicalCocaineCocaine UsersDataDecision MakingDendritic SpinesDevelopmentDiseaseDrug abuseDrug usageExploratory/Developmental GrantExploratory/Developmental Grant for Diagnostic Cancer ImagingExposure toFrequenciesGlycoproteinsHospitalsHourHumanImageImpairmentIndividualInpatientsIntoxicationMeasuresMedialMediatingModelingMonitorNeurobiologyNeurocognitiveNeuronsNeurosciences ResearchOutcomeOutpatientsPatternPerformancePharmaceutical PreparationsPilot ProjectsPlaguePositron-Emission TomographyPrefrontal CortexPrincipal InvestigatorProteinsRaceRecurrenceRegimenRegulationRelapseRewardsRodentRoleSample SizeScanningSeminalSpecificityStructureStudy SubjectSynapsesSynaptic VesiclesSynaptic plasticityTestingTimeToxicologyTranslationsUrinebasebehavioral sensitizationcingulate cortexcocaine usecohortcravingdensitydesigndrug abstinencedrug cravingeffective therapyfollow-upnicotine usenovelpreclinical studypresynapticradiotracersexsynaptic function
项目摘要
Abstract
In seminal preclinical studies nearly 20 years ago, Robinson & Kolb [1, 2] demonstrated enduring
changes in synaptic (dendritic spine) density in medial prefrontal cortex (mPFC) of rodents following
behaviorally sensitizing regimens of cocaine. Their findings suggested a potentially important
pathophysiological mechanism – aberrant structural synaptic plasticity – whereby cocaine might produce
the chronic, recalcitrant behaviors (e.g., craving, compulsive use, and relapse) so seemingly ‘hard-wired’
in those suffering from the disorder.
Our group has developed a novel radiotracer, 11C-UCB-J, for imaging synaptic density (i.e., synaptic
vesicle glycoprotein type 2A or SV2A availability) in the living human brain using positron emission
tomography (PET) [3, 4]. . Pilot data collected under the Cutting Edge Basic Research Award
(CEBRA)/R21 mechanism are compelling, we believe, and provide the first translation support for: 1)
altered (i.e., lower) synaptic density in the mPFC of individuals with CUD that is both 2) positively
correlated with the frequency (days per month) of recent cocaine use, and 3) negatively correlated with
duration of cocaine abstinence (days since last use). Together, these data suggest a dynamic model of
synaptic plasticity in which SV2A availability is “normalized” by recurrent cocaine use, only to return to
abnormal (i.e., low) levels during periods of sustained drug abstinence.
The current R01 application proposes to replicate and extend these promising preliminary findings
and more definitively test the former model through two experimental aims: Aim 1) a larger cohort of
40 CUD and 40 matched HC subjects using a single-scan, between group design, and Aim 2) the same
40 CUD subjects using a longitudinal, two-scan (baseline/pre-abstinence vs. 3 weeks of in-hospital
abstinence) within-subject design.
If confirmed, the current study would have a potentially major impact, providing powerful clinical-
translational support for the aberrant synaptic plasticity hypothesis of CUD, advancing our
neurobiological understanding of the role of drug-induced changes in synaptic function in CUD, and
ultimately, encouraging the development of more effective treatments for CUD (e.g., those based
on synaptotrophic mechanisms).
抽象的
在大约20年前的开创性临床前研究中,鲁滨逊和科尔布[1,2]证明了持久
随后的啮齿动物介质前额叶皮层(MPFC)突触(树突状脊柱)密度的变化
可卡因的行为敏感性方案。他们的发现暗示了潜在的重要
病理生理机制 - 异常结构合成可塑性 - 可卡因可能产生
慢性,顽固的行为(例如,渴望,强迫使用和救济)似乎是“硬连线”的
在患有疾病的人。
我们的小组开发了一种新型的放射性示踪剂11C-UCB-J,用于成像突触密度(即突触
囊泡糖蛋白2a型或SV2A可用性)在活体脑中使用正电子发射
断层扫描(PET)[3,4]。根据尖端基础研究奖收集的飞行员数据
我们相信(CEBRA)/R21机制令人信服,并提供了第一个翻译支持:1)
cud的个体的MPFC中改变(即下部)突触密度,这两者均为2)
与最近可卡因使用的频率(每月)相关,3)与
可卡因禁欲的持续时间(自上次使用以来的天数)。这些数据一起提出了一个动态模型
SV2A可用性通过可卡因使用“标准化”的突触可塑性,只是返回
在持续的药物戒酒期间,异常(即低)水平。
当前的R01申请提案复制并扩展这些承诺的初步发现
更明确地通过两个实验目的测试了以前的模型:目标1)较大的队列
40个CUD和40个匹配的HC受试者,使用单扫,在组设计之间和目标2)相同
40个使用纵向的二扫描的受试者(基线/预先排斥与院内3周
禁欲)受试者内部设计。
如果得到确认,当前的研究将产生潜在的重大影响,从而提供强大的临床 -
对CUD的异常合成可塑性假设的转化支持,推进了我们
神经生物学对药物诱导的突触功能变化的作用的理解,
最终,鼓励开发更有效的CUD治疗方法(例如
关于突触营养机制)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GUSTAVO Adolfo ANGARITA其他文献
GUSTAVO Adolfo ANGARITA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GUSTAVO Adolfo ANGARITA', 18)}}的其他基金
A 11C-UCB-J PET Study of Synaptic Density in Binge Eating Disorder (BED)
暴食症 (BED) 突触密度的 11C-UCB-J PET 研究
- 批准号:
10673376 - 财政年份:2023
- 资助金额:
$ 75.37万 - 项目类别:
Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C UCB J PET Study
可卡因使用障碍中异常的突触可塑性:11C UCB J PET 研究
- 批准号:
10428611 - 财政年份:2021
- 资助金额:
$ 75.37万 - 项目类别:
Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C UCB J PET Study
可卡因使用障碍中异常的突触可塑性:11C UCB J PET 研究
- 批准号:
10614579 - 财政年份:2021
- 资助金额:
$ 75.37万 - 项目类别:
Assessing Glutamate Homeostasis in Cocaine Addiction Using 7T 1H-MRS
使用 7T 1H-MRS 评估可卡因成瘾中的谷氨酸稳态
- 批准号:
9560713 - 财政年份:2017
- 资助金额:
$ 75.37万 - 项目类别:
GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration
GLP-1 激动剂可阻断可卡因欣快感和自我给药
- 批准号:
9325489 - 财政年份:2016
- 资助金额:
$ 75.37万 - 项目类别:
相似海外基金
POWS for NOWS: Using physiomarkers as an objective tool for assessing the withdrawing infant
POWS for NOWS:使用生理标志物作为评估退缩婴儿的客观工具
- 批准号:
10740629 - 财政年份:2023
- 资助金额:
$ 75.37万 - 项目类别:
Deep Brain Stimulation (DBS) For Severe Treatment Refractory Methamphetamine Use Disorder
深部脑刺激 (DBS) 治疗难治性甲基苯丙胺使用障碍
- 批准号:
10630368 - 财政年份:2022
- 资助金额:
$ 75.37万 - 项目类别:
Understanding the miRNA response to opioid withdrawal and their uses as potential biomarkers for neonatal abstinence syndrome
了解 miRNA 对阿片类药物戒断的反应及其作为新生儿戒断综合征潜在生物标志物的用途
- 批准号:
10536908 - 财政年份:2022
- 资助金额:
$ 75.37万 - 项目类别:
Assessing central muscarinic acetylcholine type-1 receptors in cocaine use disorder with 11C-LSN3172176.
使用 11C-LSN3172176 评估可卡因使用障碍中的中枢毒蕈碱乙酰胆碱 1 型受体。
- 批准号:
10367251 - 财政年份:2022
- 资助金额:
$ 75.37万 - 项目类别:
Deep Brain Stimulation (DBS) For Severe Treatment Refractory Methamphetamine Use Disorder
深部脑刺激 (DBS) 治疗难治性甲基苯丙胺使用障碍
- 批准号:
10463210 - 财政年份:2022
- 资助金额:
$ 75.37万 - 项目类别: